1. LIX1 Controls MAPK Signaling Reactivation and Contributes to GIST-T1 Cell Resistance to Imatinib
   Salomé Ruiz-Demoulin et al, 2023, International Journal of Molecular Sciences CrossRef
2. Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature
   Deborah van de Wal et al, 2022, Cancers CrossRef
3. Protein Kinase Inhibitors - Selectivity or Toxicity?
   Moran Grossman et al, 2021, Protein Kinases - Promising Targets for Anticancer Drug Research CrossRef
4. Phenotypic screening in Organ-on-a-Chip systems: a 1537 kinase inhibitor library screen on a 3D angiogenesis assay
   Camilla Soragni et al, 2024, Angiogenesis CrossRef
5. Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours
   Juan Liu et al, 2022, Molecular Oncology CrossRef